Amos Cohen

InterCure (NASDAQ: INCR) released its financial results for the first quarter of 2022 and provided shareholders with a business update. All amounts are expressed in Canadian dollars or New Israeli Shekels (NIS) unless otherwise noted. First Quarter 2022 and Recent ...

InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) revealed on Thursday that it will buy strategic assets from Cannomed (TASE: CNMD), an Israel-based company and owner of a pharmacy chain specializing in dispensing medical cannabis. The price of the acquisition was not disclosed. The...